𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized clinical trial evaluating the duration of chemotherapy in patients with primary, node-positive breast cancer

✍ Scribed by M. Schumacher; G.Bastert Bojar; K. Hübner; W. Sauerbrei; C. Schmoor; M. Olschewski


Book ID
113404302
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
154 KB
Volume
2
Category
Article
ISSN
0960-9776

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Phase 2 randomized trial of primary endo
✍ Vladimir F. Semiglazov; Vladislav V. Semiglazov; Garik A. Dashyan; Elena K. Zilt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

## Abstract ## BACKGROUND. Few studies have compared primary neoadjuvant endocrine therapy with neoadjuvant chemotherapy in breast cancer patients. The need for preoperative chemotherapy with doxorubicin or taxanes may be reduced in postmenopausal patients with estrogen receptor (ER)‐positive and/